FDA clears Integra’s Omnigraft for treating diabetic foot ulcers
Integra LifeSciences (NSDQ:IART) said today it won expanded FDA approval for its Omnigraft dermal regeneration matrix, now indicated to treat diabetic foot ulcers. The device, made of silicone, cow...
View ArticleSinocare closes $273m Nipro buy
Nipro (TYO: 8086) said today it closed the $273 million sale of its diagnostics business to China-based Sinocare, which renamed the newly acquired company to Trividia Health. Former Nipro Diagnostics...
View ArticleSpecialty plastic manufacturer Pexco acquires Scientific Plastics Corporation
Specialty plastic manufacturer Pexco said today it acquired St. Paul, Minn.-based Scientific Plastics Corporation for an undisclosed amount. Scientific Plastics Corp is a dual-certified ISO 9001 and...
View ArticleBoston Children’s CIO discusses digital health, innovation and collaboration
During the last decade or so, health care has been rapidly transforming from a reactive, paper-based system to a responsive digital model. Massachusetts, under Gov. Charlie Baker’s leadership, has...
View ArticleBard to shutter ex-Rochester Medical plants in Minnesota, laying off 185
C.R. Bard (NYSE:BCR) reportedly plans to shutter a trio of Bard Medical plants in Minnesota by the end of the year, meaning layoffs for the 185 workers employed there. “We understand that our employees...
View ArticleCooperVision, EP Global go their separate ways in contact lens deal
EP Global Communications (OTC:EPGL) said it’s parting ways with Cooper Cos. (NYSE:COO) subsidiary CooperVision on a co-development project for advanced contact lens technology. Irvine, Calif.-based EP...
View ArticleSientra soars after independent panel OKs breast implants
Shares of Sientra (NSDQ:SIEN), which hit a 52-week low last year after regulators shut down production at its sole supplier, soared today after new CEO Jeffrey Nugent said independent testing found its...
View ArticleSRS Medical wins FDA nod for expanded study of Spanner prostate stent
SRS Medical Systems said it won the FDA’s approval for a clinical trial of its Spanner prostate stent for an expanded indication, a temporary implant designed to replace indwelling and intermittent...
View ArticleSurModics slips on lowered guidance after Creagh acquisition
SurModics (NSDQ:SRDX) saw shares dip after releasing lowered guidance today for its fiscal year 2016, taking into account its $32 million acquisition of Creagh Medical. SurModics said it expects to see...
View ArticleVivasure wins CE Mark for bioabsorbable vascular closure device
Ireland-based Vivasure Medical said today it won CE Mark approval in the European Union for its bioabsorbable percutaneous vascular closure device for large-bore femoral arteriotomies. The closure...
View ArticleThe grisly art of vintage surgical illustrations
MassDevice.com takes a look at some vintage surgical illustrations: 1. Surgical instruments Surgical saws, knives and shears for operations on bone. Image © Wellcome Collection. The post The grisly art...
View ArticlePhilips moving forward on legacy lighting biz sale
Royal Philips (NYSE:PHG) is prepping its legacy lighting business for sale, according to a Reuters report. The company is looking to off load the biz so it can up its game in the healthcare market. The...
View ArticleAstora lands FDA panel date for Topas incontinence device
The FDA today scheduled a panel date to discuss the premarket approval submission from Astora Women’s Health for its Topas incontinence device. The company and federal watchdog are slated to meet in...
View ArticleMassDevice.com +3 | The top 3 medtech stories for January 8, 2016
Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the...
View ArticlePhilips and Banyan ink deal to dev handheld concussion test
Royal Philips (NYSE:PHG) and blood test developer Banyan Biomarkers said today they inked a deal to develop and commercialize a handheld blood test to test for concussions. Financial terms of the...
View ArticleAngioDynamics slumps on Q2 rev, EPS misses
AngioDynamics (NSDQ:ANGO) saw shares slump as it reported 2nd quarter earnings that missed analysts marks and shrunk from its previous year. AngioDynamics reported losses of $362,000, or 1¢ per share,...
View ArticleBioLargo raises nearly $6m for wound care tech
BioLargo subsidiary Clyra Medical Technologies said Wednesday it closed a financing deal with Sanatio Capital for $750,000 equity up front and a commitment for a $5 million operating line of credit....
View ArticleMedical isotope maker Shine Medical raises $11.5m
Shine Medical raised $11.5 million in a new round of debt financing, according to an SEC filing posted today. Monona, Wis.-based Shine Medical produces radioactive isotopes for medical applications...
View ArticleGood early data for Lumicell’s tumor-detecting system
An early trial of Lumicell’s surgical imaging agent returned promising results, according to findings published Wednesday in Science Translational Medicine. Lumicell’s surgical imaging system is made...
View ArticleBruin Biometrics pulls in $9m for sensor tech
Bruin Biometrics said today it raised $9 million in a new round of financing to support its SEM scanner designed to detect early-stage pressure ulcers. The SEM scanner is a hand-held device that uses...
View Article